Published in Int J Cancer on January 15, 2009
Cohort profile: the study of health in Pomerania. Int J Epidemiol (2010) 4.38
Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials. Hum Reprod Update (2005) 1.18
The impact of the Women's Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany. Menopause (2005) 1.12
Menopausal status and hepatic steatosis in a general female population. Gut (2007) 1.11
Menopausal hormone therapy and risk of lung cancer-Systematic review and meta-analysis. Maturitas (2009) 1.08
Gender-dependent associations between socioeconomic status and tooth loss in working age people in the Study of Health in Pomerania (SHIP), Germany. Community Dent Oral Epidemiol (2011) 0.98
The role of physical activity in the prevention of osteoporosis in postmenopausal women-An update. Maturitas (2009) 0.98
Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis. Hum Reprod Update (2007) 0.96
Gender differences in the relation between number of teeth and systolic blood pressure. J Hypertens (2006) 0.93
Menopause and determinants of quality of life in women at midlife and beyond: the study of health in pomerania (SHIP). Menopause (2007) 0.89
[Psychosocial risk factors for cancer development]. Med Klin (Munich) (2007) 0.89
Physical activity and postmenopausal health. J Br Menopause Soc (2004) 0.86
Results from WHI and HERS II--implications for women and the prescriber of HRT. Maturitas (2002) 0.86
Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003. BMC Womens Health (2007) 0.85
Hormonal contraceptive use among adolescent girls in Germany in relation to health behavior and biological cardiovascular risk factors. J Adolesc Health (2011) 0.81
Hormone therapy in perimenopause and postmenopause (HT). Interdisciplinary S3 Guideline, Association of the Scientific Medical Societies in Germany AWMF 015/062-short version. Arch Gynecol Obstet (2011) 0.80
Socioeconomic indicators and prosthetic replacement of missing teeth in a working-age population--results of the Study of Health in Pomerania (SHIP). Community Dent Oral Epidemiol (2009) 0.80
Inverse association between number of teeth and left ventricular mass in women. J Hypertens (2007) 0.79
Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. Eur Heart J (2009) 0.77
Menopausal hormone therapy does not play a major role in left ventricular hypertrophy. Maturitas (2010) 0.77
Cognitive function and menopausal hormone therapy. Hum Reprod Update (2007) 0.76
Postmenopausal hormone therapy in clinical perspective. Menopause (2008) 0.75
Re: "Reproductive hormone exposure timing and ischemic heart disease: complicated answers to a simple question" by Merz et al. [Maturitas 65 (2010) 297-298]. Maturitas (2010) 0.75
Efficacy, safety, tolerability, and potential adverse effects of low-dose oral continuous combined menopausal hormone therapies, mostly double-blind clinical trials lasting for at least 2 years. Maturitas (2007) 0.75
Re: "invited commentary: Hormone therapy and risk of coronary heart disease--why renew the focus on the early years of menopause?". Am J Epidemiol (2007) 0.75
Re: Louwman WJ et al. On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control 19:97-106. Cancer Causes Control (2008) 0.75
Re: The special extract ERr 731 of the roots of Rheum rhaponticum decreases anxiety and improves health state and general well-being in perimenopausal women. Menopause (2007) 0.75
Hospital mortality in acute myocardial infarction. JAMA (2010) 0.75
Efficacy unproven. Dtsch Arztebl Int (2008) 0.75
[Endocrinology--I]. Med Klin (Munich) (2004) 0.75
[Hormone therapy with climacteric--what remains?]. Med Monatsschr Pharm (2004) 0.75
[Communication about incontinence between affected individuals and health care providers - the patients' perspective]. Z Gerontol Geriatr (2008) 0.75
Critical comments. Maturitas (2003) 0.75
Correspondence (letter to the editor): Death Risk of Younger Women Does Not Differ Significantly From That of Older Women. Dtsch Arztebl Int (2008) 0.75
[Endocrinology. II]. Med Klin (Munich) (2004) 0.75